- Home
- GDTC vs MYSE Comparison
GDTC vs MYSE Comparison
Compare GDTC & MYSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GDTC | MYSE |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | Singapore | United States |
| Employees | N/A | 11 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4M | 14.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GDTC | MYSE |
|---|---|---|
| Price | $1.15 | $1.72 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.4K | ★ 196.3K |
| Earning Date | 04-24-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.68 | $1.31 |
| 52 Week High | $3.68 | $5.77 |
Technical Indicators
Market Signals| Indicator | GDTC | MYSE |
|---|---|---|
| Relative Strength Index (RSI) | 57.85 | 44.31 |
| Support Level | $0.93 | $1.67 |
| Resistance Level | $1.25 | $1.84 |
| Average True Range (ATR) | 0.12 | 0.15 |
| MACD | 0.03 | -0.02 |
| Stochastic Oscillator | 67.17 | 29.57 |
Price Performance
Historical ComparisonAbout GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
About MYSE Myseum Inc.
Myseum.AI Inc is an integrate proprietary privacy-first artificial intelligence (AI) and social media technology company. The Company is developing privacy-first agentic localized AI agents to assist in managing personal media such as photos, videos and messages, while maintaining privacy.